1 Followers USX:HQL - abrdn Life Sciences Investors Tekla Life Sciences Investors
Sector: Financials, Industry: Asset Management & Custody Banks
Next Earnings: 3 Jun 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 13.12    -0.03 (-0.23%)

24 Apr 2024


Loading...
Loading...
Loading...

General

CEO: Dr. Daniel R. Omstead M.S, Ph.D.

IPO: 1992-05-04

Headquarters: US

Employees: 0

Homepage

Description

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies.  It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms